Our bodies give us all the clues we need—the trick is reading them correctly.
Biomarkers can be thought of as biological indicators of health and disease. They can be detected visually—with or without imaging—or with a test.
They’ve come a long way in recent decades, from being used as simple measurements of clinical diagnosis, to now being essential tools in drug discovery and development.
Enhancements in existing analytical methods and developments of new, sophisticated and sensitive multiplex methods in gene expression analysis, proteomics, metabolomics and transcriptomics are driving the biomarkers market.
For a look at biomarkers in cancer, BCC sat down with Anjali Pradhan, Vice President of Mission Bio in San Francisco.Download Innovation Spotlight